title: Comparative performance of herpes simplex virus type 1-specific serologic assays from MRL and Meridian Diagnostics.
abstract: Two companies, MRL and Meridian Diagnostics, have developed Food and Drug Administration-approved herpes simplex virus type 1 type-specific enzyme immunoassays. The sensitivity, specificity, and overall testing efficiency of these assays were 98.2, 93.8, and 96.6% for MRL and 98.8, 99.0, and 98.1% for Meridian, making both of these kits suitable for use in the clinical lab.
authors.affiliation: Department of Clinical Sciences, University of Kentucky, Lexington, Kentucky 40536-0298, USA. jaribes@uky.edu
authors.forename: Julie A
authors.initials: JA
authors.lastname: Ribes
authors.forename: Angela
authors.initials: A
authors.lastname: Smith
authors.forename: Marie
authors.initials: M
authors.lastname: Hayes
authors.forename: Doris J
authors.initials: DJ
authors.lastname: Baker
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Winters
mesh_terms: D000914:Antibodies, Viral / Q000097:blood*; D018259:Herpesvirus 1, Human / Q000276:immunology* / Q000302:isolation & purification; D006801:Humans; D007124:Immunoenzyme Techniques; D011933:Reagent Kits, Diagnostic; D012698:Serologic Tests; D014759:Viral Envelope Proteins / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D011933:Reagent Kits, Diagnostic; D014759:Viral Envelope Proteins; C050591:glycoprotein gG-1, herpes simplex virus type 1